BGI Genomics Co., Ltd. (SHE:300676)

BGI Genomics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	3,521	3,935	4,732	5,160	6,590	5,430
Short-Term Investments	17.24	17.17	23.28	11.2	6.57	-
Trading Asset Securities	542.3	375.12	753.58	1,232	2,049	-
Cash & Short-Term Investments	4,081	4,327	5,509	6,403	8,646	5,430
Cash Growth	-17.45%	-21.46%	-13.96%	-25.94%	59.22%	345.99%
Accounts Receivable	1,867	1,679	1,464	2,223	1,244	1,576
Other Receivables	78.48	73.24	54.22	174.47	49.74	117.01
Receivables	1,946	1,752	1,518	2,397	1,294	1,693
Inventory	560.94	601.62	602.18	717.83	877.72	1,010
Other Current Assets	187.78	194.9	303.49	257.24	217.2	284.31
Total Current Assets	6,776	6,876	7,933	9,775	11,035	8,417
Property, Plant & Equipment	2,869	2,854	3,190	2,191	1,400	1,287
Long-Term Investments	1,293	1,306	1,252	1,328	898.21	449.29
Goodwill	36.47	36.47	47.11	47.11	47.11	47.11
Other Intangible Assets	363.25	359.6	418.82	410.89	245.46	146.76
Long-Term Deferred Tax Assets	269.06	230.47	241.58	236.29	200.29	162.06
Long-Term Deferred Charges	282.72	299.14	362.86	209.51	177.65	95.89
Other Long-Term Assets	597.21	580.15	167.17	187.25	250.86	589.6
Total Assets	12,486	12,542	13,613	14,385	14,254	11,195
Accounts Payable	825.68	1,137	864.6	1,025	805.32	873.23
Accrued Expenses	652.38	798.56	668.29	958.97	653.08	963.13
Short-Term Debt	10.01	24.91	-	-	5.01	563.3
Current Portion of Long-Term Debt	161.81	31.23	24.18	-	35.74	23.7
Current Portion of Leases	33.11	26.32	57.79	63.33	90.6	-
Current Income Taxes Payable	16.02	12.7	59.79	77.35	167.83	147.02
Current Unearned Revenue	564.08	637.83	699.71	929.35	1,410	840.88
Other Current Liabilities	145.81	173.59	922.68	901.93	216.41	390.86
Total Current Liabilities	2,409	2,842	3,297	3,956	3,384	3,802
Long-Term Debt	569.92	339.11	215.68	-	631.96	658
Long-Term Leases	78.99	49.7	67.75	136.68	84.44	73.89
Long-Term Unearned Revenue	26.89	15.11	15.39	19.68	36.07	49.1
Long-Term Deferred Tax Liabilities	12.93	24.89	13.13	51.56	5.19	1.48
Other Long-Term Liabilities	-	-	-	-	671.57	584.7
Total Liabilities	3,098	3,271	3,609	4,164	4,813	5,169
Common Stock	418.32	415.82	413.91	413.91	413.91	400.1
Additional Paid-In Capital	4,869	4,762	4,592	4,680	4,657	2,605
Retained Earnings	3,887	3,882	4,826	5,147	4,488	3,160
Treasury Stock	-58.33	-99.92	-115.32	-336.75	-87.95	-175.89
Comprehensive Income & Other	138.48	175.21	143.11	172	-152.57	-78.61
Total Common Equity	9,255	9,135	9,859	10,076	9,318	5,910
Minority Interest	133.59	136.75	144.78	145.09	122.87	115.64
Shareholders' Equity	9,388	9,272	10,004	10,221	9,441	6,026
Total Liabilities & Equity	12,486	12,542	13,613	14,385	14,254	11,195
Total Debt	853.84	471.27	365.4	200.01	847.75	1,319
Net Cash (Debt)	3,227	3,856	5,144	6,203	7,798	4,111
Net Cash Growth	-28.25%	-25.05%	-17.07%	-20.46%	89.68%	256.96%
Net Cash Per Share	7.87	9.35	12.47	15.12	18.94	10.30
Filing Date Shares Outstanding	419.07	412.38	379.44	409.91	409.91	396.09
Total Common Shares Outstanding	419.07	412.38	379.44	409.91	409.91	396.09
Working Capital	4,367	4,034	4,636	5,819	7,651	4,615
Book Value Per Share	22.08	22.15	25.98	24.58	22.73	14.92
Tangible Book Value	8,855	8,739	9,393	9,618	9,026	5,716
Tangible Book Value Per Share	21.13	21.19	24.76	23.46	22.02	14.43
Buildings	1,947	1,782	1,787	490.05	418.81	422.23
Machinery	2,507	2,362	2,195	1,841	1,612	1,635
Construction In Progress	23.3	205.67	418.08	752.33	38.5	53.4

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.